Skip to main content

previous disabled Page of 4
and
  1. Article

    Open Access

    Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers

    The long-term survival benefit of immune checkpoint inhibitors (ICIs) in neoadjuvant and adjuvant settings is unclear for colorectal cancers (CRC) and gastric cancers (GC) with deficiency of mismatch repair (d...

    Zhenghang Wang, Siyuan Cheng, Yanhong Yao, Shengde Liu in Cancer Immunology, Immunotherapy (2024)

  2. Article

    Open Access

    Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion

    Patient-derived organoids (PDOs) are valuable in predicting response to cancer therapy. PDOs are ideal models for precision oncologists. However, their practical application in guiding timely clinical decision...

    Sang-Hyun Lee, Kyuhwan Kim, Eunyoung Lee, Kyungmin Lee in npj Precision Oncology (2024)

  3. Article

    Open Access

    Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes

    The synergistic effects of combining arsenic compounds with imatinib against chronic myeloid leukemia (CML) have been established using in vitro data. We conducted a clinical trial to compare the efficacy of t...

    Jie Tian, Yong-** Song, Gao-Chong Zhang in Journal of Cancer Research and Clinical On… (2024)

  4. Article

    Open Access

    XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial

    Fluoropyrimidine-based combination chemotherapy plus targeted therapy is the standard initial treatment for unresectable metastatic colorectal cancer (mCRC), but the prognosis remains poor. This phase 3 trial ...

    Qiu-Zhong Pan, **g-**g Zhao, Liang Liu in Signal Transduction and Targeted Therapy (2024)

  5. Article

    Open Access

    Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses

    The Orthopoxvirus genus, especially variola virus (VARV), monkeypox virus (MPXV), remains a significant public health threat worldwide. The development of therapeutic antibodies against orthopoxviruses is largely...

    Hang Chi, Suo-Qun Zhao, Ru-Yi Chen in Signal Transduction and Targeted Therapy (2024)

  6. Article

    Open Access

    Identification macrophage signatures in prostate cancer by single-cell sequencing and machine learning

    The tumor microenvironment (TME) encompasses a variety of cells that influence immune responses and tumor growth, with tumor-associated macrophages (TAM) being a crucial component of the TME. TAM can guide pro...

    Zhen Kang, Yu-Xuan Zhao, Ren Shun Qian Qiu in Cancer Immunology, Immunotherapy (2024)

  7. Article

    Open Access

    Hepatic Zbtb18 (Zinc Finger and BTB Domain Containing 18) alleviates hepatic steatohepatitis via FXR (Farnesoid X Receptor)

    A lasting imbalance between fatty acid synthesis and consumption leads to non-alcoholic fatty liver disease (NAFLD), coupled with hepatitis and insulin resistance. Yet the details of the underlying mechanisms ...

    Lei Zhang, Jiabing Chen, **aoying Yang in Signal Transduction and Targeted Therapy (2024)

  8. Article

    Open Access

    NUDT21 interacts with NDUFS2 to activate the PI3K/AKT pathway and promotes pancreatic cancer pathogenesis

    NUDT21 (Nudix Hydrolase 21) has been shown to play an essential role in multiple biological processes. Pancreatic adenocarcinoma (PAAD) is one of the most fatal cancers in the world. However, the biological fu...

    **ao-Dong Huang, Yong-Wei Chen, Lv Tian in Journal of Cancer Research and Clinical On… (2024)

  9. Article

    Correction: Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years

    Yonghoon Choi, Nayoung Kim, Chang Yong Yun, Yoon ** Choi, Hyuk Yoon in Gastric Cancer (2023)

  10. No Access

    Article

    The significance of the microlymphangiogenesis, microangiogenesis, and combined detection of programmed cell death-1 protein (PD-1)/ki67 in gastric cancer tissues

    To investigate the relationship between the microlymphangiogenesis, microangiogenesis, and combined detection of the programmed cell death-1 protein (PD-1)/ki67 in patients with gastric cancer as well as the d...

    Yang-kun Wang, Xue-xia Lv, Zhi-qiang Wang in Journal of Cancer Research and Clinical On… (2023)

  11. No Access

    Article

    Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients develo** castration resistance after chemohormonal therapy at hormone-sensitive stage

    To explore whether 68Ga-PSMA-11 PET/CT-derived parameters could predict biochemical response to abiraterone acetate (AA) treatment and prognosis in metastatic prostate cancer patients develo** castration resist...

    Zhi-Bin Ke, Jia-Yin Chen, Qi You in Journal of Cancer Research and Clinical On… (2023)

  12. Article

    Open Access

    Characterization of mesenchymal stem cells in human fetal bone marrow by single-cell transcriptomic and functional analysis

    Bone marrow mesenchymal stromal/stem cells (MSCs) are a heterogeneous population that can self-renew and generate stroma, cartilage, fat, and bone. Although a significant progress has been made toward recogniz...

    ** Zhang, Ji Dong, **aoying Fan, Jun Yong in Signal Transduction and Targeted Therapy (2023)

  13. Article

    Open Access

    Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions

    Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide, and its treatment remains a big challenge. The pathogenesis of PD may be related to environmental and genetic factors, an...

    Xu Dong-Chen, Chen Yong, Xu Yang in Signal Transduction and Targeted Therapy (2023)

  14. Article

    Open Access

    Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

    There is considerable potential for integrating transarterial chemoembolization (TACE), programmed death-(ligand)1 (PD-[L]1) inhibitors, and molecular targeted treatments (MTT) in hepatocellular carcinoma (HCC...

    Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang in Signal Transduction and Targeted Therapy (2023)

  15. No Access

    Article

    Single-cell transcriptional profiling reveals heterogeneity and developmental trajectories of Ewing sarcoma

    Ewing sarcoma (EwS) is an aggressive malignant neoplasm composed of small round cells. The heterogeneity and developmental trajectories of EwS are uncertain.

    Bo Hong, Yi Li, Ran Yang, ShuYang Dai in Journal of Cancer Research and Clinical On… (2022)

  16. Article

    Open Access

    Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation

    Excessive inflammatory responses contribute to the pathogenesis and lethality of highly pathogenic human coronaviruses, but the underlying mechanism remains unclear. In this study, the N proteins of highly pat...

    Ting Gao, Lin Zhu, Hainan Liu, **aopeng Zhang in Signal Transduction and Targeted Therapy (2022)

  17. Article

    Open Access

    Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1

    Indoleamine 2,3-dioxygenase 1 (IDO1), the enzyme that catabolizes tryptophan (Trp) metabolism to promote regulatory T cells (Tregs) and suppress CD8+ T cells, is regulated by several intrinsic signaling pathways....

    Fan Liang, Gui-Zhen Wang, Yan Wang in Signal Transduction and Targeted Therapy (2022)

  18. Article

    Open Access

    Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients

    Azvudine (FNC) is a nucleoside analog that inhibits HIV-1 RNA-dependent RNA polymerase (RdRp). Recently, we discovered FNC an agent against SARS-CoV-2, and have taken it into Phase III trial for COVID-19 patie...

    **-Lan Zhang, Yu-Huan Li, Lu-Lu Wang in Signal Transduction and Targeted Therapy (2021)

  19. Article

    Open Access

    Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein

    SARS-CoV-2 and SARS-CoV are genetically related coronavirus and share the same cellular receptor ACE2. By replacing the VSV glycoprotein with the spikes (S) of SARS-CoV-2 and SARS-CoV, we generated two replica...

    Hongyue Li, Yuhang Zhang, Dong Li in Signal Transduction and Targeted Therapy (2021)

  20. No Access

    Article

    Regulation of prognosis-related Siglecs in the glioma microenvironment

    The anti-inflammatory environment of glioma reduces the efficacy of immunotherapies. Therefore, it is vital to transform the immunosuppressive microenvironment of glioma into a pro-inflammatory environment. Si...

    Rui Mao, Liting Zhou, Yong Yang, Peng Wang in Journal of Cancer Research and Clinical On… (2021)

previous disabled Page of 4